Latest Manufacturing News

Page 20 of 217
thl reports an 11% rise in underlying NPAT for H1 FY26 and sets a bullish FY26 guidance, underpinned by strategic divestments and cost efficiencies.
Victor Sage
Victor Sage
23 Feb 2026
Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.
Ada Torres
Ada Torres
20 Feb 2026
Aurora Labs reported a 15% revenue decline and a 12% increase in net loss for H1 2026, yet marked a strategic breakthrough with its first defence propulsion order and a successful $5.5 million capital raise.
Victor Sage
Victor Sage
20 Feb 2026
PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.
Ada Torres
Ada Torres
20 Feb 2026
Advanced Innergy Holdings Ltd (ASX:AIH) has reported a robust FY25 performance highlighted by a successful IPO and strong growth across its core segments, setting a confident tone for FY26.
Victor Sage
Victor Sage
20 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
PeopleIN reported half-year earnings in line with expectations while strategically acquiring New Zealand’s Infrawork to bolster its infrastructure recruitment footprint across the Asia Pacific.
Victor Sage
Victor Sage
20 Feb 2026
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
AdAlta Limited reported a $2.44 million loss for H1 FY26 while progressing a key CAR-T therapy collaboration and raising $2.8 million in capital. The company’s ‘East to West’ immunotherapy strategy gains momentum with regulatory tailwinds and cost efficiencies.
Ada Torres
Ada Torres
20 Feb 2026
Temas Resources has launched a major re-assay initiative on historic drill core at its La Blache project, aiming to identify valuable metals like gallium, scandium, and chromium while saving millions in drilling costs.
Maxwell Dee
Maxwell Dee
20 Feb 2026
Li-S Energy narrows its loss to $1.21 million in H1 2026, propelled by a $7.8 million ARENA grant and key manufacturing milestones including Australia’s first lithium metal foil production line. Strategic defence and aerospace partnerships bolster its commercialisation drive.
Maxwell Dee
Maxwell Dee
20 Feb 2026
Peter Warren Automotive Holdings reported a 3.2% revenue increase to $1.268 billion and more than doubled its profit after tax to $7.435 million in the first half of FY26, declaring a fully franked interim dividend of 3.0 cents per share.
Victor Sage
Victor Sage
20 Feb 2026